Compare Hims and Hers Health Inc (HIMS) vs Hershey Co (HSY) Price & Performance

Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.

The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.

Hershey (HSY) trades at $160.34, down 0.29% on the day, with the stock showing bearish technical signals despite strong recent earnings beats. The company maintains solid profitability with a 12.24% net margin and 32.81% ROE, though 2025 net income declined to $883 million from prior years. Analyst consensus remains cautious with 65.72% hold ratings, but the $204.62 price target suggests 27.6% upside potential. Recent corporate developments include international leadership changes and ongoing brand investments to drive demand.

HSY presents a mixed investment case with attractive valuation upside but near-term headwinds. The stock's current price near support levels offers entry opportunity for dividend investors, with the recent dividend resumption signaling management confidence. However, commodity cost pressures and competitive threats in the consumer staples space create execution risks. Institutional ownership trends show mixed signals with both new positions and reductions in Q2 2026.